Study Summary:
We are conducting a study of the efficacy, safety and tolerability of a new treatment for sleep disturbed, mild to moderately severe Alzheimer's patients that have a consistent caregiver at home or are in an assisted living community.
Qualified Participants Must:
Be 55 years of age or older
Have a capable caregiver to assist to and from appointments and with medications
Be able to ingest oral medications
Have sleep disturbance for at least 2 weeks
Otherwise be in general good health
Qualified Participants May Receive:
Free study related medical care and medications, and compensation for time and travel expenses for qualified participants.